Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2003
12/31/2003CN1464878A Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
12/31/2003CN1464791A Compositions for protein delivery via the pulmonary route
12/31/2003CN1464790A T cell receptor fusions and conjugates and methods of use thereof
12/31/2003CN1464789A Vaccine against the influenza virus and method for producing said virus vaccine
12/31/2003CN1463986A Type-S non-virus carrier and pharmaceutical composition containing the same
12/31/2003CN1463748A A novel highly effective immunologic adjuvant originated from plants, method for making the same and use thereof
12/31/2003CN1463747A A Newcastle disease vaccine and method for preparing the same
12/31/2003CN1463708A Oral liquid for treating common cold and coughing
12/31/2003CN1463610A Process for making liquorice tea
12/31/2003CN1132833C Vinyl-pyrrolidone cynnematin with alkali subtituent
12/31/2003CN1132829C Crystalline N-acetyl neuraminic acid derivatives and process for their preparation
12/31/2003CN1132819C 作为TNF－α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors
12/31/2003CN1132818C 用作抗病毒剂的4－氧代－1,4－二氢－3－喹啉甲酰胺 As antiviral agents 4-oxo-1,4-dihydro-3-quinoline carboxamide
12/31/2003CN1132628C 多价在卵内接种的禽疫苗 Multivalent in ovo vaccination of poultry vaccines
12/31/2003CN1132624C Compsns. comprising antifungal agent and acetate buffer
12/31/2003CN1132609C Oral liquid for removing endogenous heat
12/31/2003CN1132600C Baichun Prepn. for treating women's pelvic infection
12/31/2003CN1132599C Medicine for treating hog cholera
12/31/2003CN1132593C Mixture of white pepper and borneol and its application
12/31/2003CN1132592C Chinese medicine gel powder
12/31/2003CN1132590C Exterior-applied medicine for treating beriberi and its preparing process
12/31/2003CN1132583C Medicine for treating foot ringwoorm
12/31/2003CA2829581A1 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
12/31/2003CA2715558A1 Pharmaceutical compositions for the treatment of systemic inflammatory response syndrome
12/31/2003CA2490725A1 Devices and methodologies useful in body aesthetics
12/31/2003CA2490516A1 Honey-based skin care preparation
12/31/2003CA2490449A1 Adjuvant-free peptide vaccine
12/31/2003CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003CA2490354A1 Drug transport and delivery system
12/31/2003CA2490121A1 Modified phospholipids
12/31/2003CA2489943A1 Methods for preventing and treating microbial infections by modulating transcription factors
12/31/2003CA2489806A1 Liposomes containing biologically active compounds
12/31/2003CA2489561A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same
12/31/2003CA2489545A1 Pharmaceutical compositions for the treatment of systemic inflammatory response syndrome
12/31/2003CA2488534A1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
12/31/2003CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670448 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier
12/30/2003US6670446 N1 modified glycopeptides
12/30/2003US6670383 Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity
12/30/2003US6670377 Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof
12/30/2003US6670372 Aryl ether substituted imidazoquinolines
12/30/2003US6670363 Azole compounds as therapeutic agents for fungal infections
12/30/2003US6670360 Antiulcer, antibacterial activity against Helicobacter pylori
12/30/2003US6670342 Method of treating hepatitis delta virus infection
12/30/2003US6670341 Phosphocholine moiety covalently conjugated with one or more antiviral agents (e.g. nucleoside analogue, protease inhibitor, etc.) to a lipid backbone
12/30/2003US6670336 Aryl phosphate derivatives of d4T having anti-HIV activity
12/30/2003US6670327 bactericidal/ permeability-increasing protein (BPI) protein
12/30/2003US6670324 Cyclic peptide antifungal agents
12/30/2003US6670181 Compositions and methods for treating viral infections
12/30/2003US6670118 Method for treating papillomavirus infections
12/30/2003US6670114 Screening for molecules which modulate the binding between HCV and human apolipoprotein B
12/30/2003US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders
12/30/2003US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties
12/30/2003US6669947 Stratified and cryogenically stored vaccines, process for their preparation
12/30/2003US6669943 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/30/2003CA2280940C Use of plant extract for inhibition of haemophilus influenzae
12/30/2003CA2273960C Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
12/30/2003CA2224663C Animal feed compositions and uses of triterpenoid saponin obtained from camellia l. plants
12/30/2003CA2164638C Novel erythromycin derivatives, method for preparing same and use thereof as drugs
12/30/2003CA2163791C Anti-infective materials
12/30/2003CA2132976C Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
12/30/2003CA2067862C Stable pura vectors and uses thereof
12/28/2003CA2433237A1 Use of chloroquine, hydroxy chloroquine and 4 amino-quinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards hiv sensitive strains and towards hiv strains which are resistant to both nucleosidic and nonnucleosidic reverse transcriptase inhibitors and to proteases inhibitors
12/25/2003WO2003106461A2 Pseudopolymorphic forms of a hiv protease inhibitor
12/25/2003WO2003105846A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
12/25/2003US20030236435 Synthesis of 2-alkylcysteine via substituted thiazoline ester
12/25/2003US20030236434 Condensing cysteine with cabocyclic nitriles to form 2-arylthiazoline-4-carboxylic acid, then amidation, alkylation, hydrolyzing and optionally purifying to form 2-methylcysteine
12/25/2003US20030236426 Synthesis of benzimidate from benzoic acid
12/25/2003US20030236412 Cyclic AMP-specific phosphodiesterase inhibitors
12/25/2003US20030236404 Synthesis of 2-alkylcysteine via phase transfer catalysis
12/25/2003US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236298 Antiinflammatory agents; antihistamines; skin disorders
12/25/2003US20030236265 Bactericides; autoimmune disease; antiinflammatory agents; administering a synergistic mixture of rifamycin and another antibiotic
12/25/2003US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
12/25/2003US20030236251 Hepatitis virus viricides
12/25/2003US20030236244 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
12/25/2003US20030236243 Sterically-awkward beta-lactamase inhibitors
12/25/2003US20030236242 Viricides
12/25/2003US20030236230 Comprises 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring; for controlling weight gain in a human or higher mammal
12/25/2003US20030236229 For stimulating the immune system, treating proliferative disorders, or microbial infections
12/25/2003US20030236218 Derivative of d4T having an electron withdrawing substituent on the aryl group and an amino acid substituent on the phosphate group
12/25/2003US20030236216 For the treatment of diseases mediated by the Hepatitis C Virus
12/25/2003US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236202 Natural products and derivatives thereof for protection against neurodegenerative diseases
12/25/2003US20030235842 Map
12/25/2003US20030235835 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
12/25/2003US20030235626 Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses
12/25/2003US20030235614 Time release agents comprising drugs such as tacrolimus in solid solutions
12/25/2003US20030235610 Liposomes containing biologically active compounds
12/25/2003US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof
12/25/2003US20030235591 Comprises hepatitis B surface antigens
12/25/2003US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation
12/25/2003US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha
12/25/2003US20030235584 Method for preparing anti-MIF antibodies
12/25/2003US20030235536 Administering an aerosol, a conjugate of a therapeutic agent and an FcRn binding partner, for treating resipiratory system disorders, drug delivery of an antibody, immunizing vaccines
12/24/2003WO2003106506A1 Low molecular weight oversulfated polysaccharide
12/24/2003WO2003106505A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
1 ... 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 ... 1798